000 01571 a2200433 4500
005 20250515015647.0
264 0 _c20061024
008 200610s 0 0 eng d
022 _a0012-186X
024 7 _a10.1007/s00125-006-0161-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGarg, S
245 0 0 _aEfficacy and safety of preprandial human insulin inhalation powder versus injectable insulin in patients with type 1 diabetes.
_h[electronic resource]
260 _bDiabetologia
_cMay 2006
300 _a891-9 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdministration, Inhalation
650 0 4 _aBlood Glucose
_xdrug effects
650 0 4 _aCross-Over Studies
650 0 4 _aDiabetes Mellitus, Type 1
_xblood
650 0 4 _aDiet, Diabetic
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aEating
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xadministration & dosage
650 0 4 _aInjections, Subcutaneous
650 0 4 _aInsulin
_xadministration & dosage
650 0 4 _aInsulin Lispro
650 0 4 _aRecombinant Proteins
_xadministration & dosage
650 0 4 _aSafety
700 1 _aRosenstock, J
700 1 _aSilverman, B L
700 1 _aSun, B
700 1 _aKonkoy, C S
700 1 _ade la Peña, A
700 1 _aMuchmore, D B
773 0 _tDiabetologia
_gvol. 49
_gno. 5
_gp. 891-9
856 4 0 _uhttps://doi.org/10.1007/s00125-006-0161-3
_zAvailable from publisher's website
999 _c16116579
_d16116579